European Journal of Cardiovascular Prevention & Rehabilitation · 2009 · 25 citations · 31 references
We observed no superiority of either treatment for the ESC-03 lipid targets. Rosuvastatin 10 mg lowered mean cholesterol more effectively than simvastatin and achieved better results for the latest, more stringent, ESC target.
31